Project Details
Description
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris suis Ova Treatmen in Left-sided Ulcerative Colitis and its Effects on Mucosal Immunce State and Microbiota. IND Sponsor DAIT/NIAID/NIH and Industry Collborator Coronado Biosciences.
Status | Finished |
---|---|
Effective start/end date | 1/1/14 → 4/30/16 |
Funding
- Duke University (2033008 // 5U19AI056363-10)
- National Institute of Allergy and Infectious Diseases (2033008 // 5U19AI056363-10)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.